{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:24:37Z","timestamp":1792027477488,"version":"4.4.0"},"reference-count":116,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82260203"],"award-info":[{"award-number":["82260203"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12035-025-05243-3","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T21:44:27Z","timestamp":1753220667000},"page":"15669-15686","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["CD38-NAD(+) Axis: New Insights into Glaucoma Therapy"],"prefix":"10.1007","volume":"62","author":[{"given":"Wenyige","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haina","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulian","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,22]]},"reference":[{"key":"5243_CR1","doi-asserted-by":"crossref","unstructured":"Barkana Y, Dorairaj S (2015) Re: Tham et al.: Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis (Ophthalmology 2014; 121: 2081-90). Ophthalmology 122(7): e40-e41","DOI":"10.1016\/j.ophtha.2014.11.030"},{"issue":"18","key":"5243_CR2","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.2014.3192","volume":"311","author":"RN Weinreb","year":"2014","unstructured":"Weinreb RN, Aung T, Medeiros FA (2014) The pathophysiology and treatment of glaucoma: a review. JAMA 311(18):1901\u20131911","journal-title":"JAMA"},{"key":"5243_CR3","doi-asserted-by":"crossref","first-page":"101136","DOI":"10.1016\/j.preteyeres.2022.101136","volume":"95","author":"WK Ju","year":"2023","unstructured":"Ju WK et al (2023) Glaucomatous optic neuropathy: mitochondrial dynamics, dysfunction and protection in retinal ganglion cells. Prog Retin Eye Res 95:101136","journal-title":"Prog Retin Eye Res"},{"issue":"3","key":"5243_CR4","doi-asserted-by":"crossref","first-page":"534","DOI":"10.3390\/nu14030534","volume":"14","author":"RH Sim","year":"2022","unstructured":"Sim RH et al (2022) Treatment of glaucoma with natural products and their mechanism of action: an update. Nutrients 14(3):534","journal-title":"Nutrients"},{"issue":"4","key":"5243_CR5","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.cmet.2019.09.001","volume":"30","author":"S Lautrup","year":"2019","unstructured":"Lautrup S et al (2019) NAD(+) in brain aging and neurodegenerative disorders. Cell Metab 30(4):630\u2013655","journal-title":"Cell Metab"},{"issue":"6282","key":"5243_CR6","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1126\/science.aad4017","volume":"352","author":"DV Titov","year":"2016","unstructured":"Titov DV et al (2016) Complementation of mitochondrial electron transport chain by manipulation of the NAD+\/NADH ratio. Science 352(6282):231\u2013235","journal-title":"Science"},{"issue":"2","key":"5243_CR7","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41580-020-00313-x","volume":"22","author":"AJ Covarrubias","year":"2021","unstructured":"Covarrubias AJ et al (2021) NAD(+) metabolism and its roles in cellular processes during ageing. Nat Rev Mol Cell Biol 22(2):119\u2013141","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7","key":"5243_CR8","doi-asserted-by":"crossref","first-page":"e13943","DOI":"10.15252\/emmm.202113943","volume":"13","author":"R Zapata-Perez","year":"2021","unstructured":"Zapata-Perez R et al (2021) NAD(+) homeostasis in human health and disease. EMBO Mol Med 13(7):e13943","journal-title":"EMBO Mol Med"},{"issue":"4","key":"5243_CR9","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.cell.2014.03.026","volume":"157","author":"EF Fang","year":"2014","unstructured":"Fang EF et al (2014) Defective mitophagy in XPA via PARP-1 hyperactivation and NAD(+)\/SIRT1 reduction. Cell 157(4):882\u2013896","journal-title":"Cell"},{"key":"5243_CR10","doi-asserted-by":"crossref","first-page":"117864691877665","DOI":"10.1177\/1178646918776658","volume":"11","author":"RA Fricker","year":"2018","unstructured":"Fricker RA et al (2018) The influence of nicotinamide on health and disease in the central nervous system. Int J Tryptophan Res 11:1178646918776658","journal-title":"Int J Tryptophan Res"},{"issue":"6326","key":"5243_CR11","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1126\/science.aal0092","volume":"355","author":"PA Williams","year":"2017","unstructured":"Williams PA et al (2017) Vitamin B(3) modulates mitochondrial vulnerability and prevents glaucoma in aged mice. Science 355(6326):756\u2013760","journal-title":"Science"},{"key":"5243_CR12","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3389\/fnins.2017.00232","volume":"11","author":"PA Williams","year":"2017","unstructured":"Williams PA et al (2017) Nicotinamide and WLD(S) act together to prevent neurodegeneration in glaucoma. Front Neurosci 11:232","journal-title":"Front Neurosci"},{"issue":"4","key":"5243_CR13","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.tips.2018.02.001","volume":"39","author":"EN Chini","year":"2018","unstructured":"Chini EN et al (2018) The pharmacology of CD38\/NADase: an emerging target in cancer and diseases of aging. Trends Pharmacol Sci 39(4):424\u2013436","journal-title":"Trends Pharmacol Sci"},{"issue":"1\u20132","key":"5243_CR14","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0006-8993(97)00117-0","volume":"756","author":"M Yamada","year":"1997","unstructured":"Yamada M et al (1997) Ultrastructural localization of CD38 immunoreactivity in rat brain. Brain Res 756(1\u20132):52\u201360","journal-title":"Brain Res"},{"issue":"1\u20132","key":"5243_CR15","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0006-8993(95)00885-T","volume":"697","author":"M Mizuguchi","year":"1995","unstructured":"Mizuguchi M et al (1995) Neuronal localization of CD38 antigen in the human brain. Brain Res 697(1\u20132):235\u2013240","journal-title":"Brain Res"},{"issue":"2","key":"5243_CR16","first-page":"102","volume":"6","author":"Y Ma","year":"2014","unstructured":"Ma Y et al (2014) CD38 plays key roles in both antioxidation and cell survival of H2O2-treated primary rodent astrocytes. Int J Physiol Pathophysiol Pharmacol 6(2):102\u2013108","journal-title":"Int J Physiol Pathophysiol Pharmacol"},{"issue":"4","key":"5243_CR17","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.bbrc.2012.01.084","volume":"418","author":"Y Ma","year":"2012","unstructured":"Ma Y et al (2012) CD38 is a key enzyme for the survival of mouse microglial BV2 cells. Biochem Biophys Res Commun 418(4):714\u2013719","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"5243_CR18","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/jnc.15367","volume":"158","author":"J Roboon","year":"2021","unstructured":"Roboon J et al (2021) Inhibition of CD38 and supplementation of nicotinamide riboside ameliorate lipopolysaccharide-induced microglial and astrocytic neuroinflammation by increasing NAD(). J Neurochem 158(2):311\u2013327","journal-title":"J Neurochem"},{"issue":"11","key":"5243_CR19","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1038\/s42255-020-00298-z","volume":"2","author":"CCS Chini","year":"2020","unstructured":"Chini CCS et al (2020) CD38 ecto-enzyme in immune cells is induced during aging and regulates NAD(+) and NMN levels. Nat Metab 2(11):1284\u20131304","journal-title":"Nat Metab"},{"issue":"1","key":"5243_CR20","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40659-022-00379-1","volume":"55","author":"Y Hu","year":"2022","unstructured":"Hu Y et al (2022) A\u03b2 promotes CD38 expression in senescent microglia in Alzheimer\u2019s disease. Biol Res 55(1):10","journal-title":"Biol Res"},{"issue":"4","key":"5243_CR21","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1001\/jamaneurol.2020.5257","volume":"78","author":"DA Kia","year":"2021","unstructured":"Kia DA et al (2021) Identification of candidate Parkinson disease genes by integrating genome-wide association study, expression, and epigenetic data sets. JAMA Neurol 78(4):464\u2013472","journal-title":"JAMA Neurol"},{"key":"5243_CR22","doi-asserted-by":"crossref","first-page":"176231","DOI":"10.1016\/j.ejphar.2023.176231","volume":"962","author":"L Zeng","year":"2024","unstructured":"Zeng L et al (2024) Protective effect of the natural flavonoid naringenin in mouse models of retinal injury. Eur J Pharmacol 962:176231","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"5243_CR23","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1021\/pr4010597","volume":"13","author":"Y Hu","year":"2014","unstructured":"Hu Y et al (2014) Overexpression of CD38 decreases cellular NAD levels and alters the expression of proteins involved in energy metabolism and antioxidant defense. J Proteome Res 13(2):786\u2013795","journal-title":"J Proteome Res"},{"key":"5243_CR24","doi-asserted-by":"crossref","first-page":"109058","DOI":"10.1016\/j.exer.2022.109058","volume":"219","author":"G Chen","year":"2022","unstructured":"Chen G et al (2022) CD38 deficiency protects the retina from ischaemia\/reperfusion injury partly via suppression of TLR4\/MyD88\/NF-\u03baB signalling. Exp Eye Res 219:109058","journal-title":"Exp Eye Res"},{"issue":"10","key":"5243_CR25","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.tibs.2020.05.010","volume":"45","author":"XA Cambronne","year":"2020","unstructured":"Cambronne XA, Kraus WL (2020) Location, location, location: compartmentalization of NAD(+) synthesis and functions in mammalian cells. Trends Biochem Sci 45(10):858\u2013873","journal-title":"Trends Biochem Sci"},{"issue":"1","key":"5243_CR26","doi-asserted-by":"crossref","first-page":"16110","DOI":"10.1038\/s41598-018-34350-6","volume":"8","author":"P Brunnbauer","year":"2018","unstructured":"Brunnbauer P et al (2018) The nanomolar sensing of nicotinamide adenine dinucleotide in human plasma using a cycling assay in albumin modified simulated body fluids. Sci Rep 8(1):16110","journal-title":"Sci Rep"},{"issue":"38","key":"5243_CR27","doi-asserted-by":"crossref","first-page":"31633","DOI":"10.1074\/jbc.R112.349464","volume":"287","author":"HC Lee","year":"2012","unstructured":"Lee HC (2012) Cyclic ADP-ribose and nicotinic acid adenine dinucleotide phosphate (NAADP) as messengers for calcium mobilization. J Biol Chem 287(38):31633\u201331640","journal-title":"J Biol Chem"},{"issue":"1","key":"5243_CR28","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1006\/bbrc.1995.1485","volume":"209","author":"EN Chini","year":"1995","unstructured":"Chini EN, Dousa TP (1995) Enzymatic synthesis and degradation of nicotinate adenine dinucleotide phosphate (NAADP), a Ca(2+)-releasing agonist, in rat tissues. Biochem Biophys Res Commun 209(1):167\u2013174","journal-title":"Biochem Biophys Res Commun"},{"key":"5243_CR29","first-page":"39","volume":"75","author":"HC Lee","year":"2000","unstructured":"Lee HC (2000) Enzymatic functions and structures of CD38 and homologs. Chem Immunol 75:39\u201359","journal-title":"Chem Immunol"},{"issue":"39","key":"5243_CR30","doi-asserted-by":"crossref","first-page":"28951","DOI":"10.1074\/jbc.M604370200","volume":"281","author":"R Graeff","year":"2006","unstructured":"Graeff R et al (2006) Acidic residues at the active sites of CD38 and ADP-ribosyl cyclase determine nicotinic acid adenine dinucleotide phosphate (NAADP) synthesis and hydrolysis activities. J Biol Chem 281(39):28951\u201328957","journal-title":"J Biol Chem"},{"issue":"2","key":"5243_CR31","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1083\/jcb.200904073","volume":"186","author":"E Brailoiu","year":"2009","unstructured":"Brailoiu E et al (2009) Essential requirement for two-pore channel 1 in NAADP-mediated calcium signaling. J Cell Biol 186(2):201\u2013209","journal-title":"J Cell Biol"},{"issue":"5136","key":"5243_CR32","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1126\/science.8235624","volume":"262","author":"M Howard","year":"1993","unstructured":"Howard M et al (1993) Formation and hydrolysis of cyclic ADP-ribose catalyzed by lymphocyte antigen CD38. Science 262(5136):1056\u20131059","journal-title":"Science"},{"issue":"7","key":"5243_CR33","doi-asserted-by":"crossref","first-page":"6138","DOI":"10.1074\/jbc.M411446200","volume":"280","author":"AL Perraud","year":"2005","unstructured":"Perraud AL et al (2005) Accumulation of free ADP-ribose from mitochondria mediates oxidative stress-induced gating of TRPM2 cation channels. J Biol Chem 280(7):6138\u20136148","journal-title":"J Biol Chem"},{"key":"5243_CR34","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ceca.2019.03.002","volume":"80","author":"BA Miller","year":"2019","unstructured":"Miller BA (2019) TRPM2 in cancer. Cell Calcium 80:8\u201317","journal-title":"Cell Calcium"},{"issue":"12","key":"5243_CR35","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.3390\/biom12121891","volume":"12","author":"LL Walkon","year":"2022","unstructured":"Walkon LL, Strubbe-Rivera JO, Bazil JN (2022) Calcium overload and mitochondrial metabolism. Biomolecules 12(12):1891","journal-title":"Biomolecules"},{"issue":"6","key":"5243_CR36","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","volume":"51","author":"EP Hoffman","year":"1987","unstructured":"Hoffman EP, Brown RH Jr, Kunkel LM (1987) Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51(6):919\u2013928","journal-title":"Cell"},{"issue":"5","key":"5243_CR37","doi-asserted-by":"crossref","first-page":"e12860","DOI":"10.15252\/emmm.202012860","volume":"14","author":"A de Z\u00e9licourt","year":"2022","unstructured":"de Z\u00e9licourt A et al (2022) CD38-NADase is a new major contributor to Duchenne muscular dystrophic phenotype. EMBO Mol Med 14(5):e12860","journal-title":"EMBO Mol Med"},{"key":"5243_CR38","doi-asserted-by":"crossref","first-page":"760","DOI":"10.3389\/fimmu.2019.00760","volume":"10","author":"AL Horenstein","year":"2019","unstructured":"Horenstein AL et al (2019) CD38 in adenosinergic pathways and metabolic re-programming in human multiple myeloma cells: in-tandem insights from basic science to therapy. Front Immunol 10:760","journal-title":"Front Immunol"},{"issue":"3","key":"5243_CR39","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3390\/cells4030520","volume":"4","author":"AL Horenstein","year":"2015","unstructured":"Horenstein AL et al (2015) NAD+-metabolizing ectoenzymes in remodeling tumor-host interactions: the human myeloma model. Cells 4(3):520\u2013537","journal-title":"Cells"},{"issue":"11","key":"5243_CR40","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nrc3340","volume":"12","author":"A Chiarugi","year":"2012","unstructured":"Chiarugi A et al (2012) The NAD metabolome\u2013a key determinant of cancer cell biology. Nat Rev Cancer 12(11):741\u2013752","journal-title":"Nat Rev Cancer"},{"key":"5243_CR41","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/nyas.12485","volume":"1335","author":"V Quarona","year":"2015","unstructured":"Quarona V et al (2015) Unraveling the contribution of ectoenzymes to myeloma life and survival in the bone marrow niche. Ann N Y Acad Sci 1335:10\u201322","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"5243_CR42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.110.003285","volume":"63","author":"BB Fredholm","year":"2011","unstructured":"Fredholm BB et al (2011) International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors\u2014an update. Pharmacol Rev 63(1):1\u201334","journal-title":"Pharmacol Rev"},{"key":"5243_CR43","first-page":"146","volume":"75","author":"P Deterre","year":"2000","unstructured":"Deterre P et al (2000) CD38 in T- and B-cell functions. Chem Immunol 75:146\u2013168","journal-title":"Chem Immunol"},{"issue":"3","key":"5243_CR44","doi-asserted-by":"crossref","first-page":"768","DOI":"10.3390\/cells9030768","volume":"9","author":"R Zambello","year":"2020","unstructured":"Zambello R et al (2020) NK cells and CD38: implication for (immuno) therapy in plasma cell dyscrasias. Cells 9(3):768","journal-title":"Cells"},{"issue":"2","key":"5243_CR45","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41416-020-01048-4","volume":"124","author":"H Raskov","year":"2021","unstructured":"Raskov H et al (2021) Cytotoxic CD8(+) T cells in cancer and cancer immunotherapy. Br J Cancer 124(2):359\u2013367","journal-title":"Br J Cancer"},{"issue":"9","key":"5243_CR46","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1097\/00002030-200006160-00004","volume":"14","author":"A Savarino","year":"2000","unstructured":"Savarino A et al (2000) Role of CD38 in HIV-1 infection: an epiphenomenon of T-cell activation or an active player in virus\/host interactions? AIDS 14(9):1079\u20131089","journal-title":"AIDS"},{"issue":"1","key":"5243_CR47","first-page":"36","volume":"55","author":"J Xie","year":"2016","unstructured":"Xie J et al (2016) The correlation between HLA-DR or CD38 expression in CD8(+)T cells and CD4(+)T cells count in treatment-naive HIV\/AIDS patients. Zhonghua Nei Ke Za Zhi 55(1):36\u201339","journal-title":"Zhonghua Nei Ke Za Zhi"},{"issue":"1","key":"5243_CR48","doi-asserted-by":"crossref","first-page":"e1800128","DOI":"10.1002\/bies.201800128","volume":"41","author":"JC Rodr\u00edguez-Alba","year":"2019","unstructured":"Rodr\u00edguez-Alba JC et al (2019) HIV disease progression: overexpression of the ectoenzyme CD38 as a contributory factor? BioEssays 41(1):e1800128","journal-title":"BioEssays"},{"issue":"2","key":"5243_CR49","doi-asserted-by":"crossref","first-page":"101400","DOI":"10.1016\/j.xcrm.2024.101400","volume":"5","author":"Y Huang","year":"2024","unstructured":"Huang Y et al (2024) Inhibition of CD38 enzymatic activity enhances CAR-T cell immune-therapeutic efficacy by repressing glycolytic metabolism. Cell Rep Med 5(2):101400","journal-title":"Cell Rep Med"},{"issue":"21","key":"5243_CR50","doi-asserted-by":"crossref","first-page":"5442","DOI":"10.3390\/cancers14215442","volume":"14","author":"J Rial Saborido","year":"2022","unstructured":"Rial Saborido J et al (2022) Role of CAR T cell metabolism for therapeutic efficacy. Cancers 14(21):5442","journal-title":"Cancers"},{"issue":"1","key":"5243_CR51","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cmet.2017.10.006","volume":"27","author":"S Chatterjee","year":"2018","unstructured":"Chatterjee S et al (2018) CD38-NAD(+)Axis regulates immunotherapeutic anti-tumor T cell response. Cell Metab 27(1):85-100.e8","journal-title":"Cell Metab"},{"issue":"6","key":"5243_CR52","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.cmet.2021.04.003","volume":"33","author":"CCS Chini","year":"2021","unstructured":"Chini CCS et al (2021) Evolving concepts in NAD(+) metabolism. Cell Metab 33(6):1076\u20131087","journal-title":"Cell Metab"},{"issue":"11","key":"5243_CR53","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1089\/dna.2022.0353","volume":"41","author":"Y Tang","year":"2022","unstructured":"Tang Y et al (2022) Endoplasmic reticulum stress and oxidative stress in inflammatory diseases. DNA Cell Biol 41(11):924\u2013934","journal-title":"DNA Cell Biol"},{"issue":"4","key":"5243_CR54","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.7150\/thno.43895","volume":"11","author":"L Jiang","year":"2021","unstructured":"Jiang L et al (2021) Proteomic analysis reveals ginsenoside Rb1 attenuates myocardial ischemia\/reperfusion injury through inhibiting ROS production from mitochondrial complex I. Theranostics 11(4):1703\u20131720","journal-title":"Theranostics"},{"key":"5243_CR55","doi-asserted-by":"crossref","first-page":"7410257","DOI":"10.1155\/2016\/7410257","volume":"2016","author":"XH Guan","year":"2016","unstructured":"Guan XH et al (2016) CD38 deficiency protects the heart from ischemia\/reperfusion injury through activating SIRT1\/FOXOs-mediated antioxidative stress pathway. Oxid Med Cell Longev 2016:7410257","journal-title":"Oxid Med Cell Longev"},{"key":"5243_CR56","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.freeradbiomed.2016.04.197","volume":"100","author":"B Osborne","year":"2016","unstructured":"Osborne B et al (2016) The role of mitochondrial sirtuins in health and disease. Free Radic Biol Med 100:164\u2013174","journal-title":"Free Radic Biol Med"},{"issue":"6","key":"5243_CR57","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1159\/000492651","volume":"48","author":"LF Wang","year":"2018","unstructured":"Wang LF et al (2018) CD38 deficiency protects heart from high fat diet-induced oxidative stress via activating Sirt3\/FOXO3 pathway. Cell Physiol Biochem 48(6):2350\u20132363","journal-title":"Cell Physiol Biochem"},{"issue":"15","key":"5243_CR58","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.7150\/ijbs.65588","volume":"17","author":"L Xie","year":"2021","unstructured":"Xie L et al (2021) CD38 deficiency protects mice from high fat diet-induced nonalcoholic fatty liver disease through activating NAD(+)\/sirtuins signaling pathways-mediated inhibition of lipid accumulation and oxidative stress in hepatocytes. Int J Biol Sci 17(15):4305\u20134315","journal-title":"Int J Biol Sci"},{"issue":"9","key":"5243_CR59","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41569-020-0339-2","volume":"17","author":"Y Tan","year":"2020","unstructured":"Tan Y et al (2020) Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence. Nat Rev Cardiol 17(9):585\u2013607","journal-title":"Nat Rev Cardiol"},{"issue":"21","key":"5243_CR60","doi-asserted-by":"crossref","first-page":"16008","DOI":"10.3390\/ijms242116008","volume":"24","author":"LF Wang","year":"2023","unstructured":"Wang LF et al (2023) CD38 deficiency alleviates diabetic cardiomyopathy by coordinately inhibiting pyroptosis and apoptosis. Int J Mol Sci 24(21):16008","journal-title":"Int J Mol Sci"},{"issue":"7","key":"5243_CR61","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.3390\/nu14071421","volume":"14","author":"M M\u0142ynarczyk","year":"2022","unstructured":"M\u0142ynarczyk M et al (2022) Diet, oxidative stress, and blood serum nutrients in various types of glaucoma: a systematic review. Nutrients 14(7):1421","journal-title":"Nutrients"},{"key":"5243_CR62","doi-asserted-by":"crossref","first-page":"3187594","DOI":"10.1155\/2017\/3187594","volume":"2017","author":"S Balaiya","year":"2017","unstructured":"Balaiya S et al (2017) Sirtuins expression and their role in retinal diseases. Oxid Med Cell Longev 2017:3187594","journal-title":"Oxid Med Cell Longev"},{"issue":"5932","key":"5243_CR63","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1126\/science.1169956","volume":"324","author":"EM Dioum","year":"2009","unstructured":"Dioum EM et al (2009) Regulation of hypoxia-inducible factor 2alpha signaling by the stress-responsive deacetylase sirtuin 1. Science 324(5932):1289\u20131293","journal-title":"Science"},{"issue":"7","key":"5243_CR64","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.1167\/iovs.11-9259","volume":"53","author":"S Balaiya","year":"2012","unstructured":"Balaiya S, Ferguson LR, Chalam KV (2012) Evaluation of sirtuin role in neuroprotection of retinal ganglion cells in hypoxia. Invest Ophthalmol Vis Sci 53(7):4315\u20134322","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"5243_CR65","doi-asserted-by":"crossref","first-page":"5097","DOI":"10.1167\/iovs.13-12157","volume":"54","author":"L Zuo","year":"2013","unstructured":"Zuo L et al (2013) SIRT1 promotes RGC survival and delays loss of function following optic nerve crush. Invest Ophthalmol Vis Sci 54(7):5097\u20135102","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"20","key":"5243_CR66","doi-asserted-by":"crossref","first-page":"6384","DOI":"10.1128\/MCB.00426-08","volume":"28","author":"NR Sundaresan","year":"2008","unstructured":"Sundaresan NR et al (2008) SIRT3 is a stress-responsive deacetylase in cardiomyocytes that protects cells from stress-mediated cell death by deacetylation of Ku70. Mol Cell Biol 28(20):6384\u20136401","journal-title":"Mol Cell Biol"},{"issue":"26","key":"5243_CR67","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1038\/onc.2011.37","volume":"30","author":"EL Bell","year":"2011","unstructured":"Bell EL et al (2011) SirT3 suppresses hypoxia inducible factor 1\u03b1 and tumor growth by inhibiting mitochondrial ROS production. Oncogene 30(26):2986\u20132996","journal-title":"Oncogene"},{"key":"5243_CR68","doi-asserted-by":"crossref","first-page":"1244765","DOI":"10.3389\/fcell.2023.1244765","volume":"11","author":"J Cheng","year":"2023","unstructured":"Cheng J, Keuthan CJ, Esumi N (2023) The many faces of SIRT6 in the retina and retinal pigment epithelium. Front Cell Dev Biol 11:1244765","journal-title":"Front Cell Dev Biol"},{"issue":"8","key":"5243_CR69","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1016\/j.bbapap.2010.05.002","volume":"1804","author":"J Yi","year":"2010","unstructured":"Yi J, Luo J (2010) SIRT1 and p53, effect on cancer, senescence and beyond. Biochim Biophys Acta 1804(8):1684\u20131689","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"5243_CR70","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cell.2008.10.052","volume":"136","author":"TL Kawahara","year":"2009","unstructured":"Kawahara TL et al (2009) SIRT6 links histone H3 lysine 9 deacetylation to NF-kappaB-dependent gene expression and organismal life span. Cell 136(1):62\u201374","journal-title":"Cell"},{"issue":"1","key":"5243_CR71","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s12974-021-02250-8","volume":"18","author":"Y Zhao","year":"2021","unstructured":"Zhao Y et al (2021) NAD(+) improves cognitive function and reduces neuroinflammation by ameliorating mitochondrial damage and decreasing ROS production in chronic cerebral hypoperfusion models through Sirt1\/PGC-1\u03b1 pathway. J Neuroinflammation 18(1):207","journal-title":"J Neuroinflammation"},{"key":"5243_CR72","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/978-3-319-75402-4_68","volume":"1074","author":"JB Lin","year":"2018","unstructured":"Lin JB et al (2018) Role of sirtuins in retinal function under basal conditions. Adv Exp Med Biol 1074:561\u2013567","journal-title":"Adv Exp Med Biol"},{"key":"5243_CR73","doi-asserted-by":"crossref","first-page":"845330","DOI":"10.3389\/fnagi.2022.845330","volume":"14","author":"W Wan","year":"2022","unstructured":"Wan W et al (2022) Regulation of mitophagy by sirtuin family proteins: a vital role in aging and age-related diseases. Front Aging Neurosci 14:845330","journal-title":"Front Aging Neurosci"},{"issue":"4","key":"5243_CR74","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.neuron.2020.08.012","volume":"108","author":"M Linnerbauer","year":"2020","unstructured":"Linnerbauer M, Wheeler MA, Quintana FJ (2020) Astrocyte crosstalk in CNS inflammation. Neuron 108(4):608\u2013622","journal-title":"Neuron"},{"issue":"9","key":"5243_CR75","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/nri2818","volume":"10","author":"MR M\u00fcller","year":"2010","unstructured":"M\u00fcller MR, Rao A (2010) NFAT, immunity and cancer: a transcription factor comes of age. Nat Rev Immunol 10(9):645\u2013656","journal-title":"Nat Rev Immunol"},{"issue":"35","key":"5243_CR76","doi-asserted-by":"crossref","first-page":"e2211310119","DOI":"10.1073\/pnas.2211310119","volume":"119","author":"T Meyer","year":"2022","unstructured":"Meyer T et al (2022) NAD(+) metabolism drives astrocyte proinflammatory reprogramming in central nervous system autoimmunity. Proc Natl Acad Sci U S A 119(35):e2211310119","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"5243_CR77","doi-asserted-by":"crossref","first-page":"245","DOI":"10.4062\/biomolther.2012.20.3.245","volume":"20","author":"SS Yoon","year":"2012","unstructured":"Yoon SS, Jo SA (2012) Mechanisms of amyloid-\u03b2 peptide clearance: potential therapeutic targets for Alzheimer\u2019s disease. Biomol Ther (Seoul) 20(3):245\u2013255","journal-title":"Biomol Ther (Seoul)"},{"issue":"7","key":"5243_CR78","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul H et al (2017) A unique microglia type associated with restricting development of Alzheimer\u2019s disease. Cell 169(7):1276-1290.e17","journal-title":"Cell"},{"issue":"4","key":"5243_CR79","doi-asserted-by":"crossref","first-page":"e60921","DOI":"10.1371\/journal.pone.0060921","volume":"8","author":"G Krabbe","year":"2013","unstructured":"Krabbe G et al (2013) Functional impairment of microglia coincides with beta-amyloid deposition in mice with Alzheimer-like pathology. PLoS ONE 8(4):e60921","journal-title":"PLoS ONE"},{"issue":"1","key":"5243_CR80","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/ana.24425","volume":"78","author":"E Blacher","year":"2015","unstructured":"Blacher E et al (2015) Alzheimer\u2019s disease pathology is attenuated in a CD38-deficient mouse model. Ann Neurol 78(1):88\u2013103","journal-title":"Ann Neurol"},{"issue":"8","key":"5243_CR81","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/jnnp-2019-322338","volume":"91","author":"J Jankovic","year":"2020","unstructured":"Jankovic J, Tan EK (2020) Parkinson\u2019s disease: etiopathogenesis and treatment. J Neurol Neurosurg Psychiatry 91(8):795\u2013808","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"5243_CR82","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41531-023-00591-0","volume":"9","author":"XJ Gu","year":"2023","unstructured":"Gu XJ et al (2023) Expanding causal genes for Parkinson\u2019s disease via multi-omics analysis. NPJ Parkinsons Dis 9(1):146","journal-title":"NPJ Parkinsons Dis"},{"issue":"12","key":"5243_CR83","first-page":"1062","volume":"46","author":"XY Liu","year":"2010","unstructured":"Liu XY, Chen XM, Wang NL (2010) Is glaucoma a central nervous system disease: re-evaluation. Zhonghua Yan Ke Za Zhi 46(12):1062\u20131065","journal-title":"Zhonghua Yan Ke Za Zhi"},{"issue":"1","key":"5243_CR84","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0002-9394(01)01196-5","volume":"133","author":"AU Bayer","year":"2002","unstructured":"Bayer AU et al (2002) Association of glaucoma with neurodegenerative diseases with apoptotic cell death: Alzheimer\u2019s disease and Parkinson\u2019s disease. Am J Ophthalmol 133(1):135\u2013137","journal-title":"Am J Ophthalmol"},{"issue":"7\u20139","key":"5243_CR85","first-page":"317","volume":"109","author":"I Jankowska-Lech","year":"2007","unstructured":"Jankowska-Lech I et al (2007) Glaucoma neuropathy and neuropathy in multiple sclerosis\u2013common elements of pathogenesis? Klin Oczna 109(7\u20139):317\u2013320","journal-title":"Klin Oczna"},{"issue":"1","key":"5243_CR86","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13024-022-00524-0","volume":"17","author":"LK Wareham","year":"2022","unstructured":"Wareham LK et al (2022) Solving neurodegeneration: common mechanisms and strategies for new treatments. Mol Neurodegener 17(1):23","journal-title":"Mol Neurodegener"},{"key":"5243_CR87","doi-asserted-by":"crossref","first-page":"110171","DOI":"10.1016\/j.intimp.2023.110171","volume":"119","author":"F Wang","year":"2023","unstructured":"Wang F et al (2023) Rapamycin suppresses neuroinflammation and protects retinal ganglion cell loss after optic nerve crush. Int Immunopharmacol 119:110171","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"5243_CR88","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1167\/iovs.65.5.36","volume":"65","author":"Y Pang","year":"2024","unstructured":"Pang Y et al (2024) CD38 deficiency protects mouse retinal ganglion cells through activating the NAD+\/Sirt1 pathway in ischemia-reperfusion and optic nerve crush models. Invest Ophthalmol Vis Sci 65(5):36","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"5243_CR89","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1007\/s00417-022-05556-2","volume":"260","author":"N Zhang","year":"2022","unstructured":"Zhang N et al (2022) Differential susceptibility of retinal ganglion cell subtypes against neurodegenerative diseases. Graefes Arch Clin Exp Ophthalmol 260(6):1807\u20131821","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"21","key":"5243_CR90","doi-asserted-by":"crossref","first-page":"e103420","DOI":"10.15252\/embj.2019103420","volume":"39","author":"C Sun","year":"2020","unstructured":"Sun C et al (2020) Re-equilibration of imbalanced NAD metabolism ameliorates the impact of telomere dysfunction. Embo j 39(21):e103420","journal-title":"Embo j"},{"issue":"7","key":"5243_CR91","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/iub.2584","volume":"74","author":"C Fortunato","year":"2022","unstructured":"Fortunato C, Mazzola F, Raffaelli N (2022) The key role of the NAD biosynthetic enzyme nicotinamide mononucleotide adenylyltransferase in regulating cell functions. IUBMB Life 74(7):562\u2013572","journal-title":"IUBMB Life"},{"issue":"5","key":"5243_CR92","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/cdd.2014.164","volume":"22","author":"M Di Stefano","year":"2015","unstructured":"Di Stefano M et al (2015) A rise in NAD precursor nicotinamide mononucleotide (NMN) after injury promotes axon degeneration. Cell Death Differ 22(5):731\u2013742","journal-title":"Cell Death Differ"},{"issue":"1","key":"5243_CR93","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40478-024-01736-9","volume":"12","author":"H Zeng","year":"2024","unstructured":"Zeng H et al (2024) Loss of Sarm1 reduces retinal ganglion cell loss in chronic glaucoma. Acta Neuropathol Commun 12(1):23","journal-title":"Acta Neuropathol Commun"},{"issue":"12","key":"5243_CR94","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.1007\/s12035-020-02063-5","volume":"57","author":"Y Kitaoka","year":"2020","unstructured":"Kitaoka Y et al (2020) Axonal protection by nicotinamide riboside via SIRT1-autophagy pathway in TNF-induced optic nerve degeneration. Mol Neurobiol 57(12):4952\u20134960","journal-title":"Mol Neurobiol"},{"issue":"7","key":"5243_CR95","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1111\/ceo.13818","volume":"48","author":"F Hui","year":"2020","unstructured":"Hui F et al (2020) Improvement in inner retinal function in glaucoma with nicotinamide (vitamin B3) supplementation: a crossover randomized clinical trial. Clin Exp Ophthalmol 48(7):903\u2013914","journal-title":"Clin Exp Ophthalmol"},{"issue":"3","key":"5243_CR96","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0167-8140(95)01581-Z","volume":"36","author":"J Dragovic","year":"1995","unstructured":"Dragovic J et al (1995) Nicotinamide pharmacokinetics in patients. Radiother Oncol 36(3):225\u2013228","journal-title":"Radiother Oncol"},{"issue":"1","key":"5243_CR97","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0167-8140(96)01896-8","volume":"43","author":"JH Kaanders","year":"1997","unstructured":"Kaanders JH et al (1997) Administration of nicotinamide during a five- to seven-week course of radiotherapy: pharmacokinetics, tolerance, and compliance. Radiother Oncol 43(1):67\u201373","journal-title":"Radiother Oncol"},{"issue":"8","key":"5243_CR98","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1001\/jamaoncol.2022.1634","volume":"8","author":"M Nadeau Nguyen","year":"2022","unstructured":"Nadeau Nguyen M et al (2022) Association of daratumumab use with ocular events in a case series of US adults. JAMA Oncol 8(8):1209\u20131210","journal-title":"JAMA Oncol"},{"key":"5243_CR99","doi-asserted-by":"crossref","first-page":"110831","DOI":"10.1016\/j.exger.2020.110831","volume":"132","author":"N Braidy","year":"2020","unstructured":"Braidy N, Liu Y (2020) NAD+ therapy in age-related degenerative disorders: a benefit\/risk analysis. Exp Gerontol 132:110831","journal-title":"Exp Gerontol"},{"issue":"6","key":"5243_CR100","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.cmet.2016.09.013","volume":"24","author":"KF Mills","year":"2016","unstructured":"Mills KF et al (2016) Long-Term administration of nicotinamide mononucleotide mitigates age-associated physiological decline in mice. Cell Metab 24(6):795\u2013806","journal-title":"Cell Metab"},{"issue":"1","key":"5243_CR101","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1001\/jamaophthalmol.2021.4576","volume":"140","author":"CG De Moraes","year":"2022","unstructured":"De Moraes CG et al (2022) Nicotinamide and pyruvate for neuroenhancement in open-angle glaucoma: a phase 2 randomized clinical trial. JAMA Ophthalmol 140(1):11\u201318","journal-title":"JAMA Ophthalmol"},{"issue":"6a","key":"5243_CR102","doi-asserted-by":"crossref","first-page":"22c","DOI":"10.1016\/j.amjcard.2006.11.018","volume":"99","author":"JR Guyton","year":"2007","unstructured":"Guyton JR, Bays HE (2007) Safety considerations with niacin therapy. Am J Cardiol 99(6a):22c\u201331c","journal-title":"Am J Cardiol"},{"issue":"22","key":"5243_CR103","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1056\/NEJM197311292892208","volume":"289","author":"SL Winter","year":"1973","unstructured":"Winter SL, Boyer JL (1973) Hepatic toxicity from large doses of vitamin B3 (nicotinamide). N Engl J Med 289(22):1180\u20131182","journal-title":"N Engl J Med"},{"issue":"1","key":"5243_CR104","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0002-9343(92)90018-7","volume":"92","author":"JI Rader","year":"1992","unstructured":"Rader JI, Calvert RJ, Hathcock JN (1992) Hepatic toxicity of unmodified and time-release preparations of niacin. Am J Med 92(1):77\u201381","journal-title":"Am J Med"},{"issue":"2","key":"5243_CR105","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1507\/endocrj.EJ19-0313","volume":"67","author":"J Irie","year":"2020","unstructured":"Irie J et al (2020) Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men. Endocr J 67(2):153\u2013160","journal-title":"Endocr J"},{"issue":"1","key":"5243_CR106","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1038\/s41467-018-03421-7","volume":"9","author":"CR Martens","year":"2018","unstructured":"Martens CR et al (2018) Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD(+) in healthy middle-aged and older adults. Nat Commun 9(1):1286","journal-title":"Nat Commun"},{"issue":"4","key":"5243_CR107","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.cmet.2011.08.014","volume":"14","author":"J Yoshino","year":"2011","unstructured":"Yoshino J et al (2011) Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. Cell Metab 14(4):528\u2013536","journal-title":"Cell Metab"},{"issue":"1","key":"5243_CR108","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1159\/000225695","volume":"40","author":"B Toth","year":"1983","unstructured":"Toth B (1983) Lack of carcinogenicity of nicotinamide and isonicotinamide following lifelong administration to mice. Oncology 40(1):72\u201375","journal-title":"Oncology"},{"issue":"6","key":"5243_CR109","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.ccell.2014.10.002","volume":"26","author":"KS Tummala","year":"2014","unstructured":"Tummala KS et al (2014) Inhibition of de novo NAD(+) synthesis by oncogenic URI causes liver tumorigenesis through DNA damage. Cancer Cell 26(6):826\u2013839","journal-title":"Cancer Cell"},{"issue":"3","key":"5243_CR110","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41556-019-0287-4","volume":"21","author":"T Nacarelli","year":"2019","unstructured":"Nacarelli T et al (2019) NAD(+) metabolism governs the proinflammatory senescence-associated secretome. Nat Cell Biol 21(3):397\u2013407","journal-title":"Nat Cell Biol"},{"key":"5243_CR111","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12883-015-0272-x","volume":"15","author":"AN Long","year":"2015","unstructured":"Long AN et al (2015) Effect of nicotinamide mononucleotide on brain mitochondrial respiratory deficits in an Alzheimer\u2019s disease-relevant murine model. BMC Neurol 15:19","journal-title":"BMC Neurol"},{"key":"5243_CR112","doi-asserted-by":"crossref","first-page":"106694","DOI":"10.1016\/j.nbd.2024.106694","volume":"202","author":"M Sekiya","year":"2024","unstructured":"Sekiya M et al (2024) Decreased plasma nicotinamide and altered NAD(+) metabolism in glial cells surrounding A\u03b2 plaques in a mouse model of Alzheimer\u2019s disease. Neurobiol Dis 202:106694","journal-title":"Neurobiol Dis"},{"issue":"3","key":"5243_CR113","doi-asserted-by":"crossref","first-page":"e13316","DOI":"10.1111\/bpa.13316","volume":"35","author":"J Cai","year":"2025","unstructured":"Cai J et al (2025) Aerobic exercise improves astrocyte mitochondrial quality and transfer to neurons in a mouse model of Alzheimer\u2019s disease. Brain Pathol 35(3):e13316","journal-title":"Brain Pathol"},{"issue":"6220","key":"5243_CR114","doi-asserted-by":"crossref","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhl\u00e9n","year":"2015","unstructured":"Uhl\u00e9n M et al (2015) Tissue-based map of the human proteome. Science 347(6220):1260419","journal-title":"Science"},{"issue":"5","key":"5243_CR115","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s00011-024-01863-y","volume":"73","author":"PG Alabarse","year":"2024","unstructured":"Alabarse PG et al (2024) The NADase CD38 is a central regulator in gouty inflammation and a novel druggable therapeutic target. Inflamm Res 73(5):739\u2013751","journal-title":"Inflamm Res"},{"key":"5243_CR116","doi-asserted-by":"crossref","first-page":"12948","DOI":"10.1038\/ncomms12948","volume":"7","author":"SA Trammell","year":"2016","unstructured":"Trammell SA et al (2016) Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. Nat Commun 7:12948","journal-title":"Nat Commun"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05243-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-05243-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05243-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T11:04:12Z","timestamp":1761908652000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-05243-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,22]]},"references-count":116,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["5243"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-05243-3","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,22]]},"assertion":[{"value":"18 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with patients or animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval and Consent to Participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}